GABAergic neurons are a key cell type in a Drosophila model of PARK14/PLA2G6-associated neurodegeneration

The causes of sporadic Parkinson's Disease (PD) are still unclear, despite its prevalence. By contrast, inherited parkinsonian disorders have a clear genetic basis and have been studied intensively in laboratory organisms, including <i>Drosophila melanogaster.</i> Because inherited parkinsonian disorders clinically resemble sporadic PD, it has been suggested that they may share an underlying etiology. Loss of function mutations in the gene <i>PLA2G6</i> give rise to inherited neurodegenerative diseases including autosomal recessive early onset parkinsonism (PARK14). Using RNAi to deplete the <i>Drosophila PLA2G6</i> homolog <i>iPLA2-VIA</i>, we asked whether subsets of neurons, identified by their neurotransmitter usage, were more susceptible to loss of this gene. To model movement disorders connected with <i>PLA2G6-</i>associated neurodegeneration, we used the well-established climbing assay. Our results demonstrated that loss of <i>iPLA2-VIA</i> in GABAergic neurons alone strongly affected locomotor ability in aged flies, similar to pan-neuronal knockdown. Depletion of <i>iPLA2-VIA</i> in both dopaminergic and serotonergic neurons weakly affected locomotor ability as well. Depletion in other neuronal subsets did not disrupt locomotion. Furthermore, reintroducing wild-type <i>iPLA2-VIA</i> into only the dopaminergic neurons of fly knockouts improved climbing performance slightly, while reintroduction into GABAergic neurons rescued climbing performance strikingly, as well as lifespan. Although much research on this gene has focused on the dopaminergic neurons, whose degeneration leads to clinical parkinsonism, our results highlight the importance of GABAergic neurons to <i>PLA2G6-</i>associated neurodegeneration. Because sporadic PD is not thought to impact most GABAergic neurons directly, our data support the idea that sporadic PD and PARK14 have distinct etiologies despite overlapping clinical presentations.

Authors

Institutions

Publication Details

Journal
Frontiers in Neuroscience
Published
2025-12-01
DOI
https://doi.org/10.3389/fnins.2025.1534243
Primary Topic
Neurological diseases and metabolism
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

GABAergic neurons are a key cell type in a Drosophila model of PARK14/PLA2G6-associated neurodegeneration

Eli Yaakov Saks, Adam Levy, Matthew R. Silver, Anne Moskowitz et al.
Frontiers in Neuroscience
Neurological diseases and metabolism
article

GABAergic neurons are a key cell type in a Drosophila model of PARK14/PLA2G6-associated neurodegeneration

Eli Yaakov Saks, Adam Levy, Matthew R. Silver, Anne Moskowitz, Jeffrey Rothstein, Shimshon Benji, Josefa Steinhauer, Michael A. Gerber, Jeremy Purow, Edmund Jacobson, R Saperstein, E.W. Carroll, Benjamin I. Coplin, Noah S. Meimoun, David T. Levitt, Yehuda Z. Mazin, William Z. Besharim, Yosef Y. Scher, Yair Y. Cantor, Amiel Rimberg, Yisroel D. Schwarcz, Yitzchak F. Stein, Yisrael Y. Wiener, Moshe B. Davidovics, Aryeh L. Levenbrown, Philip M. Hirschprung
article en

Abstract

The causes of sporadic Parkinson's Disease (PD) are still unclear, despite its prevalence. By contrast, inherited parkinsonian disorders have a clear genetic basis and have been studied intensively in laboratory organisms, including <i>Drosophila melanogaster.</i> Because inherited parkinsonian disorders clinically resemble sporadic PD, it has been suggested that they may share an underlying etiology. Loss of function mutations in the gene <i>PLA2G6</i> give rise to inherited neurodegenerative diseases including autosomal recessive early onset parkinsonism (PARK14). Using RNAi to deplete the <i>Drosophila PLA2G6</i> homolog <i>iPLA2-VIA</i>, we asked whether subsets of neurons, identified by their neurotransmitter usage, were more susceptible to loss of this gene. To model movement disorders connected with <i>PLA2G6-</i>associated neurodegeneration, we used the well-established climbing assay. Our results demonstrated that loss of <i>iPLA2-VIA</i> in GABAergic neurons alone strongly affected locomotor ability in aged flies, similar to pan-neuronal knockdown. Depletion of <i>iPLA2-VIA</i> in both dopaminergic and serotonergic neurons weakly affected locomotor ability as well. Depletion in other neuronal subsets did not disrupt locomotion. Furthermore, reintroducing wild-type <i>iPLA2-VIA</i> into only the dopaminergic neurons of fly knockouts improved climbing performance slightly, while reintroduction into GABAergic neurons rescued climbing performance strikingly, as well as lifespan. Although much research on this gene has focused on the dopaminergic neurons, whose degeneration leads to clinical parkinsonism, our results highlight the importance of GABAergic neurons to <i>PLA2G6-</i>associated neurodegeneration. Because sporadic PD is not thought to impact most GABAergic neurons directly, our data support the idea that sporadic PD and PARK14 have distinct etiologies despite overlapping clinical presentations.

Frontiers in NeuroscienceVol. 19
Yeshiva University (US)
Yeshiva University, National Institutes of Health
Openalex Percentile: Top 56%
Neurological diseases and metabolism
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.